The TACtful Trial: A first-in-human multi-centre trial of BCMA specific T-cell antigen coupler infusion, generated from cryopreserved G-CSF-mobilized peripheral blood, in patients with relapsed and refractory multiple myeloma. Grant uri icon

  •  
  • Overview
  •  
  • Affiliation
  •  
  • View All
  •  

date/time interval

  • October 1, 2023 - September 30, 2028

total award amount

  • CAD 305618